RxSight Stock Forecast
NASDAQ: RXSTHealth CareOphthalmic GoodsUSD
Market open · Delayed 15 min · as of Oct 8, 1:39 PM ET
RXST analyst consensus
Consensus (10 analysts)
none
Avg. price target
$7.57+57.05%
- Strong buy 1
- Buy 0
- Hold 7
- Sell 0
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 10 Wall Street analysts covering RxSight (2026-10-08), 1 rate the stock a buy or strong buy, 7 rate it a hold and 2 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $7.57, with a high estimate of $11.00 and a low estimate of $5.50. The average target implies upside of 57.1% from the current price of $4.82.
The spread between the highest and lowest targets is 100.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for RXST.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 10% |
| Buy | 0 | 0% |
| Hold | 7 | 70% |
| Sell | 0 | 0% |
| Strong sell | 2 | 20% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $5.50 | +14.11% |
| Average target | $7.57 | +57.05% |
| High target | $11.00 | +128.22% |